Get notified of page updates

Colorectal Cancer: Medications to Reduce Risk

Learn about medications to reduce colorectal cancer risk. Stay up to date by signing up for our community newsletter.
Glossary on
off

Medications to Lower Colorectal Cancer Risk

Doctors sometimes use the term to describe the use of medications to lower the risk for cancer. Several different drugs and dietary supplements have been studied to learn if they can lower the risk for colorectal cancer. Only a few have shown enough benefit to be useful.

Medications and supplements can have side effects. It is important for people to discuss the benefits and risks of with their doctor. People who choose to take medication to lower risk still need to undergo colorectal cancer screening. 


Non-steroidal anti-inflammatory drugs (NSAIDs)

Much of the research on medications to lower colorectal cancer risk have focused on pain medications known as NSAIDS. These drugs have been studied in both average-risk and high-risk people. 

Aspirin to lower colorectal cancer risk

  • In people at average risk for colorectal cancer, long term use of aspirin can reduce the risk of colorectal and colorectal cancer. 
  • For people at high risk for colorectal cancer, multiple studies have shown a benefit of aspirin or other non-steroidal anti-inflammatory drugs (NSAIDS).
    • In people with , daily aspirin may decrease the risk for colon cancer and other cancers. In one study, people who took 600 mg of aspirin daily for two years or more had a 60 percent decrease in their risk for colorectal cancer.
    • More studies are needed to help experts understand the best dose and duration of aspirin to protect people with from colorectal cancer. 

Other anti-inflammatory drugs

  • In people with the rare syndrome Familial Adenomatous Polyposis (FAP), caused by an  in the gene, the drugs Sulindac and celexicob have been shown to lower the risk for .

Research on other drugs to lower the colorectal cancer risk

  • Vaccines are being studied in clinical trials to see if they can lower the risk for colorectal cancer in people with
  • A new drug, REC-4881 is being studied in a clinical trial to learn how well it can lower the risk for cancer in people with FAP. 
  • Other medications and dietary supplements have been studied through clinical trials, some of which may be enrolling high-risk people.
  • Currently, there is not enough evidence to support using of any of these other agents to lower the risk for colorectal cancer.

More Resources


Find Experts
Find Experts

The following resources can help you locate an expert near you.

Finding gastroenterologists

Other ways to find experts

  • The National Cancer Institute (NCI)-designated comprehensive cancer centers deliver cutting-edge cancer care to patients in communities across the United States. Most centers have specialized screening and prevention centers for high-risk people. Find a center near you and learn about its specific research capabilities, programs, and initiatives.
  • Register for the FORCE Message Boards to get referrals from other members. Once you register, you can post on the Find a Specialist board to connect with other people who share your situation.
Last updated October 05, 2024